Contact

All Stories

  1. miRNAs and T cell-mediated Immune Response in Disease

    Article • The Yale Journal of Biology and Medicine, June 2025, Yale Journal of Biology and Medicine

    Prof Paul Holvoet

  2. Aging and Metabolic Reprogramming of Adipose-Derived Stem Cells Affect Molecular Mechanisms Related to Cardiovascular Diseases

    Article • Cells, December 2023, MDPI AG

    Prof Paul Holvoet

  3. Noncoding RNAs Controlling Oxidative Stress in Cancer

    Article • Cancers, February 2023, MDPI AG

    Prof Paul Holvoet

  4. The marker of cobalamin deficiency, plasma methylmalonic acid, may help identifying lysosomal iron trapping in patients. Its possible utility for heart failure

    Article • Redox Biology, August 2021, Elsevier

    Prof Paul Holvoet

  5. Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome

    Article • International Journal of Environmental Research and Public Health, February 2021, MDPI AG

    Prof Paul Holvoet, Professor Tomas Krilavicius

  6. Myeloid Krüppel-like factor 2 is a critical regulator of metabolic inflammation

    Article • Nature Communications, November 2020, Springer Science + Business Media

    Prof Paul Holvoet

  7. RNA-sequencing reveals that STRN, ZNF484 and WNK1 add to the value of mitochondrial MT-COI and COX10 as markers of unstable coronary artery disease

    Article • PLOS One, December 2019, PLOS

    Prof Paul Holvoet

  8. Single-cell transcriptomics–based MacSpectrum reveals macrophage activation signatures in diseases

    Article • JCI Insight, May 2019, American Society for Clinical Investigation

    Prof Paul Holvoet

  9. Circular RNAs as Potential Theranostics in the Cardiovascular System

    Article • Molecular Therapy — Nucleic Acids, December 2018, Elsevier

    Prof Paul Holvoet

  10. Peer review: (r)evolution needed

    Article • Cardiovascular Research, October 2017, Oxford University Press (OUP)

    Prof Paul Holvoet

  11. Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs

    Article • PLOS One, January 2017, PLOS

    Prof Paul Holvoet

  12. Extracellular Vesicles in Cardiovascular Theranostics

    Article • Theranostics, January 2017, Ivyspring International Publisher

    Prof Paul Holvoet

  13. Functional Role of Cardiovascular Exosomes in Myocardial Injury and Atherosclerosis

    Article • January 2017, Springer Science + Business Media

    Prof Paul Holvoet

  14. Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease

    Article • Journal of the American Heart Association, December 2016, Wolters Kluwer Health

    Prof Paul Holvoet

  15. A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction

    Article • Scientific Reports, November 2016, Springer Science + Business Media

    Prof Paul Holvoet

  16. Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review

    Article • Cardiovascular Research, June 2016, European Society of Cardiology

    Prof Paul Holvoet

  17. Exosomes

    Article • Current Opinion in Lipidology, October 2015, Wolters Kluwer Health

    Prof Paul Holvoet

  18. Low cytochrome oxidase 4I1 links mitochondrial dysfunction to obesity and type 2 diabetes in humans and mice

    Article • International Journal of Obesity, April 2015, Springer Science + Business Media

    Prof. dr. Roman Vangoitsenhoven, Prof Paul Holvoet

  19. Stevia-derived compounds attenuate the toxic effects of ectopic lipid accumulation in the liver of obese mice: A transcriptomic and metabolomic study

    Article • Food and Chemical Toxicology, March 2015, Elsevier

    Prof Paul Holvoet

  20. Welcome to Cardiovascular Research in 2015

    Article • Cardiovascular Research, December 2014, European Society of Cardiology

    Prof Paul Holvoet

  21. Biomechanical factors in atherosclerosis: mechanisms and clinical implications

    Article • European Heart Journal, September 2014, European Society of Cardiology

    Prof Paul Holvoet

  22. Rosiglitazone and Fenofibrate Exacerbate Liver Steatosis in a Mouse Model of Obesity and Hyperlipidemia. A Transcriptomic and Metabolomic Study

    Article • Journal of Proteome Research, January 2014, American Chemical Society (ACS)

    Prof Paul Holvoet

  23. Bedside to bench: a look at experimental research with a clinical trial checklist

    Article • Cardiovascular Research, December 2013, European Society of Cardiology

    Prof Paul Holvoet

  24. MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases

    Article • Current Pharmaceutical Design, August 2013, Bentham Science Publishers

    Prof Paul Holvoet

  25. Examining the association between salivary cortisol levels and subclinical measures of atherosclerosis: The Multi-Ethnic Study of Atherosclerosis

    Article • Psychoneuroendocrinology, July 2013, Elsevier

    Prof Paul Holvoet

  26. MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease

    Article • Cardiovascular Research, June 2013, European Society of Cardiology

    Prof Paul Holvoet

  27. Biomechanical factors and macrophages in plaque stability

    Article • Cardiovascular Research, May 2013, European Society of Cardiology

    Prof Paul Holvoet

  28. PPAR Agonist-Induced Reduction of Mcp1 in Atherosclerotic Plaques of Obese, Insulin-Resistant Mice Depends on Adiponectin-Induced Irak3 Expression

    Article • PLOS One, April 2013, PLOS

    Prof Paul Holvoet

  29. Hematopoietic stem/progenitor cell and HDL

    Article • PLOS One, November 2012, PLOS

    Dr Yingmei Feng, Prof Paul Holvoet

  30. Decreased miR-181a Expression in Monocytes of Obese Patients Is Associated with the Occurrence of Metabolic Syndrome and Coronary Artery Disease

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2012, Endocrine Society

    Prof Paul Holvoet

  31. CD36 Inhibitors Reduce Postprandial Hypertriglyceridemia and Protect against Diabetic Dyslipidemia and Atherosclerosis

    Article • PLOS One, May 2012, PLOS

    Prof Paul Holvoet

  32. Decrease of miR-146b-5p in Monocytes during Obesity Is Associated with Loss of the Anti-Inflammatory but Not Insulin Signaling Action of Adiponectin

    Article • PLOS One, February 2012, PLOS

    Prof Paul Holvoet

  33. Mitochondrial Reactive Oxygen Species and Risk of Atherosclerosis

    Article • Current Atherosclerosis Reports, February 2012, Springer Science + Business Media

    Prof Paul Holvoet

  34. Interleukin-1 Receptor-Associated Kinase-3 Is a Key Inhibitor of Inflammation in Obesity and Metabolic Syndrome

    Article • PLOS One, January 2012, PLOS

    Prof Paul Holvoet

  35. Stress in Obesity and Associated Metabolic and Cardiovascular Disorders

    Article • Scientifica, January 2012, Hindawi Publishing Corporation

    Prof Paul Holvoet

  36. Dietary antioxidants and forced expiratory volume in 1 s decline: the Health, Aging and Body Composition study

    Article • European Respiratory Journal, October 2011, European Respiratory Society (ERS)

    Prof Paul Holvoet

  37. MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis

    Article • The FASEB Journal, April 2011, Federation of American Societies For Experimental Biology (FASEB)

    Prof Paul Holvoet

  38. Association of endothelial and oxidative stress with metabolic syndrome and subclinical atherosclerosis: multi-ethnic study of atherosclerosis

    Article • European Journal of Clinical Nutrition, April 2011, Springer Science + Business Media

    Prof Paul Holvoet

  39. Differential Associations of Weight Dynamics With Coronary Artery Calcium Versus Common Carotid Artery Intima-Media Thickness

    Article • American Journal of Epidemiology, June 2010, Oxford University Press (OUP)

    Prof Paul Holvoet

  40. Statins for Calcific Aortic Valve Stenosis: Into Oblivion After SALTIRE and SEAS? An Extensive Review from Bench to Bedside

    Article • Current Problems in Cardiology, June 2010, Elsevier

    Prof Paul Holvoet

  41. Telomere length and its associations with oxidized-LDL carotid artery distensibility and smoking

    Article • Frontiers in Bioscience-Elite, January 2010, Frontiers in Bioscience

    Prof Paul Holvoet

  42. Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice

    Article • International Journal of Obesity, December 2009, Springer Science + Business Media

    Prof Paul Holvoet

  43. Increased PAFAH and Oxidized Lipids Are Associated With Inflammation and Atherosclerosis in Hypercholesterolemic Pigs

    Article • Arteriosclerosis Thrombosis and Vascular Biology, December 2009, Wolters Kluwer Health

    Prof Paul Holvoet

  44. The vicious circle between oxidative stress and inflammation in atherosclerosis

    Article • Journal of Cellular and Molecular Medicine, November 2009, Wiley

    Prof Paul Holvoet

  45. Food-restriction in obese dyslipidaemic diabetic mice partially restores basal contractility but not contractile reserve

    Article • European Journal of Heart Failure, November 2009, Wiley

    Prof Paul Holvoet

  46. Obesity-Asthma Association

    Article • CHEST Journal, October 2009, Elsevier

    Prof Paul Holvoet

  47. Oxidative Stress and Insulin Resistance: The Coronary Artery Risk Development in Young Adults study

    Article • Diabetes Care, April 2009, American Diabetes Association

    Prof Paul Holvoet

  48. Relationship of lipoprotein-associated phospholipase A2and oxidized low density lipoprotein in carotid atherosclerosis

    Article • Journal of Lipid Research, April 2009, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof Paul Holvoet

  49. Influence of exercise at lower and higher intensity on blood pressure and cardiovascular risk factors at older age

    Article • Journal of Hypertension, April 2009, Wolters Kluwer Health

    Prof Paul Holvoet

  50. Oxidized LDL and the metabolic syndrome

    Article • Future Lipidology, December 2008, Future Medicine

    Prof Paul Holvoet

  51. Thrombospondin-1 Deficiency Accelerates Atherosclerotic Plaque Maturation in ApoE −/− Mice

    Article • Circulation Research, November 2008, Wolters Kluwer Health

    Prof Paul Holvoet

  52. Angio-Associated Migratory Cell Protein and Smooth Muscle Cell Migration in Development of Restenosis and Atherosclerosis⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily...

    Article • Journal of the American College of Cardiology, July 2008, Elsevier

    Prof Paul Holvoet

  53. Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic Syndrome

    Article • JAMA, May 2008, American Medical Association (AMA)

    Prof Paul Holvoet

  54. Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis

    Article • British Journal of Pharmacology, February 2008, Wiley

    Prof Paul Holvoet

  55. Rosuvastatin increases vascular endothelial PPARγ expression and corrects blood pressure variability in obese dyslipidaemic mice

    Article • European Heart Journal, December 2007, European Society of Cardiology

    Prof Paul Holvoet

  56. Defective Leptin/Leptin Receptor Signaling Improves Regulatory T Cell Immune Response and Protects Mice From Atherosclerosis

    Article • Arteriosclerosis Thrombosis and Vascular Biology, December 2007, Wolters Kluwer Health

    Prof Paul Holvoet

  57. Oxidized low-density lipoprotein-induced expression of ABCA1 in blood monocytes precedes coronary atherosclerosis and is associated with plaque complexity in hypercholesterolemic pigs

    Article • Journal of Thrombosis and Haemostasis, December 2007, Wiley

    Prof Paul Holvoet

  58. Pioglitazone Improves Myocardial Blood Flow and Glucose Utilization in Nondiabetic Patients With Combined Hyperlipidemia

    Article • Journal of the American College of Cardiology, November 2007, Elsevier

    Prof Paul Holvoet

  59. Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: Relation to liver, muscle and regional body fat content

    Article • Atherosclerosis, November 2007, Elsevier

    Prof Paul Holvoet

  60. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA)

    Article • Atherosclerosis, September 2007, Elsevier

    Prof Paul Holvoet

  61. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness

    Article • Cardiovascular Research, August 2007, European Society of Cardiology

    Prof Paul Holvoet

  62. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice

    Article • British Journal of Pharmacology, June 2007, Wiley

    Prof Paul Holvoet

  63. The complex link between oxidised low-density lipoprotein and unstable angina

    Article • Journal of Cardiovascular Medicine, May 2007, Wolters Kluwer Health

    Prof Paul Holvoet

  64. Gelatinolytic Activity in Atherosclerotic Plaques Is Highly Localized and Is Associated With Both Macrophages and Smooth Muscle Cells In Vivo

    Article • Circulation, February 2007, Wolters Kluwer Health

    Prof Paul Holvoet

  65. The Importance of Catch-up Growth after Early Malnutrition for the Programming of Obesity in Male Rat*

    Article • Obesity, August 2006, Wiley

    Prof Paul Holvoet

  66. Oxidized Low-Density Lipoprotein Correlates Positively With Toll-Like Receptor 2 and Interferon Regulatory Factor-1 and Inversely With Superoxide Dismutase-1 Expression

    Article • Arteriosclerosis Thrombosis and Vascular Biology, July 2006, Wolters Kluwer Health

    Prof Paul Holvoet

  67. Human Paraoxonase-1 Overexpression Inhibits Atherosclerosis in a Mouse Model of Metabolic Syndrome

    Article • Arteriosclerosis Thrombosis and Vascular Biology, July 2006, Wolters Kluwer Health

    Prof Paul Holvoet

  68. Obesity, the metabolic syndrome, and oxidized LDL

    Article • American Journal of Clinical Nutrition, June 2006, Oxford University Press (OUP)

    Prof Paul Holvoet

  69. Oxidized LDL and the Metabolic Syndrome

    Article • Arteriosclerosis Thrombosis and Vascular Biology, April 2006, Wolters Kluwer Health

    Prof Paul Holvoet

  70. Metabolic Syndrome and the Risk of Cardiovascular Disease in Older Adults

    Article • Journal of the American College of Cardiology, April 2006, Elsevier

    Prof Paul Holvoet

  71. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes

    Article • Journal of Cell Science, April 2006, The Company of Biologists

    Prof Paul Holvoet

  72. Analytical Performance and Diagnostic Accuracy of Immunometric Assays for the Measurement of Circulating Oxidized LDL

    Article • Clinical Chemistry, April 2006, Oxford University Press (OUP)

    Prof Paul Holvoet

  73. Peroxisome Proliferator-Activated Receptor-α,γ-Agonist Improves Insulin Sensitivity and Prevents Loss of Left Ventricular Function in Obese Dyslipidemic Mice

    Article • Arteriosclerosis Thrombosis and Vascular Biology, April 2006, Wolters Kluwer Health

    Prof Paul Holvoet

  74. Application of NIRS in Mice: A Study Comparing the Oxygenation of Cerebral Blood and Main Tissue Oxygenation of Mice and Rat

    Article • January 2006, Springer Science + Business Media

    Prof Paul Holvoet

  75. Lipoprotein Peroxidation and Mobility Limitation

    Article • Archives of Internal Medicine, October 2005, American Medical Association (AMA)

    Prof Paul Holvoet

  76. Obesity, Regional Body Fat Distribution, and the Metabolic Syndrome in Older Men and Women

    Article • Archives of Internal Medicine, April 2005, American Medical Association (AMA)

    Prof Paul Holvoet

  77. Weight Loss–Associated Induction of Peroxisome Proliferator–Activated Receptor-α and Peroxisome Proliferator–Activated Receptor-γ Correlate With Reduced Atherosclerosis and Improved Cardiovascular Function in Obese Insulin-Resistant Mice

    Article • Circulation, November 2004, Wolters Kluwer Health

    Prof Paul Holvoet

  78. Oxidized LDL and coronary heart disease

    Article • Acta Cardiologica, November 2004, Peeters Publishers

    Prof Paul Holvoet

  79. Molecular and Functional Characterization of Ovine Cardiac Valve-Derived Interstitial Cells in Primary Isolates and Cultures

    Article • Tissue Engineering, September 2004, Mary Ann Liebert Inc

    Prof Paul Holvoet

  80. Gene Therapy Approaches for Cardiovascular Diseases

    Article • Current Gene Therapy, June 2004, Bentham Science Publishers

    Prof Paul Holvoet

  81. The Metabolic Syndrome, Circulating Oxidized LDL, and Risk of Myocardial Infarction in Well-Functioning Elderly People in the Health, Aging, and Body Composition Cohort

    Article • Diabetes, March 2004, American Diabetes Association

    Prof Paul Holvoet

  82. α-Helix Formation Is Required for High Affinity Binding of Human Apolipoprotein A-I to Lipids

    Article • Journal of Biological Chemistry, March 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof Paul Holvoet

  83. Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly

    Article • Arteriosclerosis Thrombosis and Vascular Biology, August 2003, Wolters Kluwer Health

    Prof Paul Holvoet

  84. Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI

    Article • Cardiovascular Research, July 2003, European Society of Cardiology

    Prof Paul Holvoet

  85. Domain Structure and Lipid Interaction in Human Apolipoproteins A-I and E, a General Model

    Article • Journal of Biological Chemistry, April 2003, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof Paul Holvoet

  86. Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice

    Article • Circulation, April 2003, Wolters Kluwer Health

    Prof Paul Holvoet

  87. Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs

    Article • Cardiovascular Research, March 2003, European Society of Cardiology

    Prof Paul Holvoet

  88. Increased Levels of Low-Density Lipoprotein Oxidation in Patients with Familial Hypercholesterolemia and in End-Stage Renal Disease Patients on Hemodialysis

    Article • Laboratory Investigation, January 2003, Springer Science + Business Media

    Prof Paul Holvoet

  89. Effects of Homocysteine on the Cellular Responses of Murine Endothelial Cells Culturedin Vitro

    Article • Annals of the New York Academy of Sciences, November 2002, Wiley

    Prof Paul Holvoet

  90. Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs

    Article • Cardiovascular Research, October 2002, European Society of Cardiology

    Prof Paul Holvoet

  91. Hypercholesterolemia in Minipigs Impairs Left Ventricular Response to Stress

    Article • Circulation, August 2002, Wolters Kluwer Health

    Prof Paul Holvoet

  92. Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty

    Article • Cardiovascular Research, August 2002, European Society of Cardiology

    Prof Paul Holvoet

  93. Effects of Enrichment of Fibroblasts with Unesterified Cholesterol on the Efflux of Cellular Lipids to Apolipoprotein A-I

    Article • Journal of Biological Chemistry, January 2002, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof Paul Holvoet

  94. Antineutrophil cytoplasmatic antibodies in patients with premature atherosclerosis: prevalence and association with risk factors

    Article • Journal of Internal Medicine, January 2002, Wiley

    Prof Paul Holvoet

  95. Identification of the phospholipase A2 isoforms that contribute to arachidonic acid release in hypoxic endothelial cells: limits of phospholipase A2 inhibitors

    Article • Biochemical Pharmacology, January 2002, Elsevier

    Prof Paul Holvoet

  96. Arg123-Tyr166 Domain of Human ApoA-I Is Critical for HDL-Mediated Inhibition of Macrophage Homing and Early Atherosclerosis in Mice

    Article • Arteriosclerosis Thrombosis and Vascular Biology, December 2001, Wolters Kluwer Health

    Prof Paul Holvoet

  97. Oxidized LDL and HDL: antagonists in atherothrombosis

    Article • The FASEB Journal, October 2001, Federation of American Societies For Experimental Biology (FASEB)

    Prof Paul Holvoet

  98. S-nitrosothiols do not induce oxidative stress, contrary to other nitric oxide donors, in cultures of vascular endothelial or smooth muscle cells

    Article • European Journal of Pharmacology, August 2001, Elsevier

    Prof Paul Holvoet

  99. Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 11/2 years

    Article • Kidney International, June 2001, Elsevier

    Prof Paul Holvoet

  100. Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor–Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E–Deficient Mice

    Article • Circulation, May 2001, Wolters Kluwer Health

    Prof Paul Holvoet

  101. Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease

    Article • Arteriosclerosis Thrombosis and Vascular Biology, May 2001, Wolters Kluwer Health

    Prof Paul Holvoet

  102. Smooth Muscle Cells Influence Monocyte Response to LDL as well as Their Adhesion and Transmigration in a Coculture Model of the Arterial Wall

    Article • Journal of Vascular Research, January 2001, Karger Publishers

    Prof Paul Holvoet

  103. Restenosis and gene therapy

    Article • Expert Opinion on Biological Therapy, January 2001, Informa Healthcare

    Prof Paul Holvoet

  104. HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice

    Article • The FASEB Journal, October 2000, Federation of American Societies For Experimental Biology (FASEB)

    Prof Paul Holvoet

  105. Effect of Overexpression of Human Apo A-I in C57BL/6 and C57BL/6 Apo E–Deficient Mice on 2 Lipoprotein-Associated Enzymes, Platelet-Activating Factor Acetylhydrolase and Paraoxonase

    Article • Arteriosclerosis Thrombosis and Vascular Biology, October 2000, Wolters Kluwer Health

    Prof Paul Holvoet

  106. Oxidized Low Density Lipoprotein Is a Prognostic Marker of Transplant-Associated Coronary Artery Disease

    Article • Arteriosclerosis Thrombosis and Vascular Biology, March 2000, Wolters Kluwer Health

    Prof Paul Holvoet

  107. The Arg123-Tyr166 Central Domain of Human ApoAI Is Critical for Lecithin:Cholesterol Acyltransferase–Induced Hyperalphalipoproteinemia and HDL Remodeling in Transgenic Mice

    Article • Arteriosclerosis Thrombosis and Vascular Biology, February 2000, Wolters Kluwer Health

    Prof Paul Holvoet

  108. Sustained Expression of Human Apolipoprotein A-I after Adenoviral Gene Transfer in C57BL/6 Mice: Role of Apolipoprotein A-I Promoter, Apolipoprotein A-I Introns, and Human Apolipoprotein E Enhancer

    Article • Human Gene Therapy, January 2000, Mary Ann Liebert Inc

    Prof Paul Holvoet

  109. Endothelial Dysfunction, Oxidation of Low‐Density Lipoprotein, and Cardiovascular Disease

    Article • Therapeutic Apheresis and Dialysis, November 1999, Wiley

    Prof Paul Holvoet

  110. Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes

    Article • JAMA, May 1999, American Medical Association (AMA)

    Prof Paul Holvoet

  111. Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis

    Article • Expert Opinion on Investigational Drugs, May 1999, Informa Healthcare

    Prof Paul Holvoet

  112. Apolipoprotein-mediated Plasma Membrane Microsolubilization

    Article • Journal of Biological Chemistry, January 1999, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof Paul Holvoet

  113. Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease

    Article • Circulation, October 1998, Wolters Kluwer Health

    Prof Paul Holvoet

  114. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.

    Article • Journal of Clinical Investigation, July 1998, American Society for Clinical Investigation

    Prof Paul Holvoet

  115. Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis

    Article • Atherosclerosis, April 1998, Elsevier

    Prof Paul Holvoet

  116. LDL Hypercholesterolemia Is Associated With Accumulation of Oxidized LDL, Atherosclerotic Plaque Growth, and Compensatory Vessel Enlargement in Coronary Arteries of Miniature Pigs

    Article • Arteriosclerosis Thrombosis and Vascular Biology, March 1998, Wolters Kluwer Health

    Prof Paul Holvoet

  117. Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease

    Article • Arteriosclerosis Thrombosis and Vascular Biology, January 1998, Wolters Kluwer Health

    Prof Paul Holvoet

  118. Effects of Adenovirus-Mediated Human Apo A-I Gene Transfer on Neointima Formation After Endothelial Denudation in Apo E–Deficient Mice

    Article • Circulation, December 1997, Wolters Kluwer Health

    Prof Paul Holvoet

  119. Prevention of Fatty Streak Formation of 17β-Estradiol Is Not Mediated by the Production of Nitric Oxide in Apolipoprotein E– Deficient Mice

    Article • Circulation, November 1997, Wolters Kluwer Health

    Prof Paul Holvoet

  120. β-VLDL Hypercholesterolemia Relative to LDL Hypercholesterolemia Is Associated With Higher Levels of Oxidized Lipoproteins and a More Rapid Progression of Coronary Atherosclerosis in Rabbits

    Article • Arteriosclerosis Thrombosis and Vascular Biology, November 1997, Wolters Kluwer Health

    Prof Paul Holvoet

  121. Thrombosis and atherosclerosis

    Article • Current Opinion in Lipidology, October 1997, Wolters Kluwer Health

    Prof Paul Holvoet

  122. Role of the Arg123–Tyr166Paired Helix of Apolipoprotein A-I in Lecithin:Cholesterol Acyltransferase Activation

    Article • Journal of Biological Chemistry, June 1997, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof Paul Holvoet

  123. 2 The oxidation hypothesis of atherosclerosis

    Article • Atherosclerosis, May 1997, Elsevier

    Prof Paul Holvoet

  124. Role of the Carboxy-Terminal Domain of Human Apolipoprotein AI in High-Density-Lipoprotein Metabolism. A Study Based on Deletion and Substitution Variants in Transgenic Mice

    Article • FEBS Journal, May 1997, Wiley

    Prof Paul Holvoet

  125. Effects of Deletion of the Carboxyl-terminal Domain of ApoA-I or of Its Substitution with Helices of ApoA-II onin Vitroandin VivoLipoprotein Association

    Article • Journal of Biological Chemistry, August 1996, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof Paul Holvoet

  126. Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants

    Article • Biochemistry, October 1995, American Chemical Society (ACS)

    Prof Paul Holvoet

  127. Lipid Lowering and Enhancement of Fibrinolysis With Niacin

    Article • Circulation, August 1995, Wolters Kluwer Health

    Prof Paul Holvoet

  128. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.

    Article • Journal of Clinical Investigation, June 1995, American Society for Clinical Investigation

    Prof Paul Holvoet

  129. Oxidized lipoproteins in atherosclerosis and thrombosis

    Article • The FASEB Journal, December 1994, Wiley

    Prof Paul Holvoet

  130. Stimulation with a monoclonal antibody (mAb4E4) of scavenger receptor-mediated uptake of chemically modified low density lipoproteins by THP-1-derived macrophages enhances foam cell generation.

    Article • Journal of Clinical Investigation, January 1994, American Society for Clinical Investigation

    Prof Paul Holvoet

  131. Thrombolytic profiles of clot-targeted plasminogen activators. Parameters determining potency and initial and maximal rates.

    Article • Circulation, March 1993, Wolters Kluwer Health

    Prof Paul Holvoet

  132. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase

    Article • FEBS Journal, December 1992, Wiley

    Prof Paul Holvoet

  133. Time course of thrombolysis induced by intravenous bolus or infusion of tissue plasminogen activator in a rabbit jugular vein thrombosis model.

    Article • Circulation, January 1989, Wolters Kluwer Health

    Prof Paul Holvoet

  134. Experimental Pulmonary Embolus in the Rat

    Article • Journal of Cardiovascular Pharmacology, November 1988, Wolters Kluwer Health

    Prof Paul Holvoet

  135. Characterization of functional domains in human tissue-type plasminogen activator with the use of monoclonal antibodies

    Article • FEBS Journal, July 1986, Wiley

    Prof Paul Holvoet

  136. A monoclonal antibody directed against the high-affinity lysine-binding site (LBS) of human plasminogen. Role of LBS in the regulation of fibrinolysis

    Article • FEBS Journal, May 1986, Wiley

    Prof Paul Holvoet